Paclitaxel: new uses for an old drug

References

• Goldspiel BR Clinical overview of the taxanes Pharmacotherapy 1997 17 110S 125S 9322878
   PubMed Web of Science ®Google Scholar
• Ledwitch K Ogburn R Cox J Taxol: efficacy against oral squamous cell carcinoma Mini Rev Med Chem 2013 13 509 521 23373651
   PubMed Web of Science ®Google Scholar
• Rowinsky EK The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents Annu Rev Med 1997 48 353 374 9046968
   PubMed Web of Science ®Google Scholar
• Mekhail TM Markman M Paclitaxel in cancer therapy Expert Opin Pharmacother 2002 3 6 755 766 12036415
   PubMedGoogle Scholar
• Zhou J Zhong DW Wang QW Paclitaxel ameliorates fibrosis in hepatic stellate cells via inhibition of TGF-β/Smad activity World J Gasteroenterol 2010 16 26 3330 3334
   PubMed Web of Science ®Google Scholar
• Liu X Zhu S Wang T Paclitaxel modulates TGF-β signaling in scleroderma skin grafts in immunodeficient mice PLoS Med 2005 2 12 e354 16250671
   PubMed Web of Science ®Google Scholar
• Zhang D Sun L Xian W Low-dose paclitaxel ameliorates renal fibrosis in rat UUO model by inhibition of TGF-β/Smad activity Lab Invest 2010 90 3 436 447 20142807
   PubMed Web of Science ®Google Scholar
• Sun L Zhang D Fuyou Liu Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192 J Pathol 2011 225 3 364 377 21984124
   PubMed Web of Science ®Google Scholar
• Mirzapoiazova T Kolosova IA Moreno L Sammani S Garcia JG Verin AD Suppression of endotoxin-induced inflammation by paclitaxel Eur Respir J 2007 30 3 429 435 17537765
   PubMed Web of Science ®Google Scholar
• Hellal F Hurtado A Ruschel J Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury Science 2011 331 6019 928 931 21273450
   PubMed Web of Science ®Google Scholar
• Tepe G Zeller T Albrecht T Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 2008 358 7 689 699 18272892
   PubMed Web of Science ®Google Scholar
• Stone GW Ellis SG Cox DA A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 2004 350 3 221 231 14724301
   PubMed Web of Science ®Google Scholar
• Bharadwaj R Yu H The spindle checkpoint, aneuploidy, and cancer Oncogene 2004 23 11 2016 2027 15021889
   PubMed Web of Science ®Google Scholar
• Brito DA Yang Z Rieder CL Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied The Journal of Cell Biology 2008 182 4 623 629 18710927
   PubMed Web of Science ®Google Scholar
• Jordan MA Wilson L Microtubules as a target for anticancer drugs Nat Rev Cancer 2004 4 4 253 265 15057285
   PubMed Web of Science ®Google Scholar
• Ganguly A Yang H Cabral F Paclitaxel-dependent cell lines reveal a novel drug activity Mol Cancer Ther 2010 9 11 2914 2923 20978163
   PubMed Web of Science ®Google Scholar
• Löwe J Li H Downing KH Refined structure of alpha beta-tubulin at 3.5 A resolution J Mol Biol 2001 313 5 1045 1057 11700061
   PubMed Web of Science ®Google Scholar
• Panis C Lemos LG Victorino VJ Immunological effects of taxol and adryamicin in breast cancer patients Cancer Immunol Immunother 2012 61 4 481 488 21959683
   PubMed Web of Science ®Google Scholar
• Alexandre J Hu Y Lu W Pelicano H Huang P Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species Cancer Res 2007 67 8 3512 3517 17440056
   PubMed Web of Science ®Google Scholar
• Hadzic T Aykin-Burns N Zhu Y Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing via H2O2-mediated oxidative stress Free Radic Biol Med 2010 48 8 1024 1033 20083194
   PubMed Web of Science ®Google Scholar
• Sevko A Michels T Vrohlings M Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model J Immunol 2013 190 5 2464 2471 23359505
   PubMed Web of Science ®Google Scholar
• Sevko A Kremer V Falk C Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice J Immunotoxicol 2012 9 3 275 281 22449053
   PubMed Web of Science ®Google Scholar
• Gan L Chen S Wang Y Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer Cancer Res 2009 69 21 8386 8394 19826044
   PubMed Web of Science ®Google Scholar
• Derynck R Zhang YE Smad-dependent and Smad-independent pathways in TGF-beta family signalling Nature 2003 425 6958 577 584 14534577
   PubMed Web of Science ®Google Scholar
• Dong C Li Z Alvarez R Microtubule binding to Smads may regulate TGF beta activity Mol Cell 2000 5 1 27 34 10678166
   PubMed Web of Science ®Google Scholar
• Brahn E Tang C Banquerigo ML Regression of collagen-induced arthritis with Taxol, a microtubule stabilizer Arthritis Rheum 1994 37 6 839 845 7911665
   PubMed Web of Science ®Google Scholar
• Karbalay-Doust S Noorafshan A Pourshahid SM Taxol and taurine protect the renal tissue of rats after unilateral ureteral obstruction: a stereological survey Korean J Urol 2012 53 5 360 367 22670197
   PubMedGoogle Scholar
• Wang C Song X Li Y Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation PLoS One 2013 8 8 e70725 23967091
   PubMed Web of Science ®Google Scholar
• Tsukada T Fushida S Harada S Low-dose paclitaxel modulates tumour fibrosis in gastric cancer Int J Oncol 2013 42 4 1167 1174 23443842
   PubMed Web of Science ®Google Scholar
• Kupfer I Balguerie X Courville P Scleroderma-like cutaneous lesions induced by paclitaxel: a case study J Am Acad Dermatol 2003 48 2 279 281 12582404
   PubMed Web of Science ®Google Scholar
• Eisenbeilss C Weizel J Wolff H Scleroderma-like skin changes following administration of paclitaxel for the treatment of ovarian carcinoma J Dtsch Dermatol Ges 2003 1 6 468 470 16295141
   PubMedGoogle Scholar
• Ostoros G Pretz A Fillinger J Fatal pulmonary fibrosis induced by paclitaxel: a case report and review of the literature Int J Gynecol Cancer 2006 16 1 391 393 16515630
   PubMed Web of Science ®Google Scholar
• Sako T Burioka N Watanabe M A case of stage IV advanced lung adenocarcinoma treated effectively using paclitaxel with the fibrosing radiographically on the chest CT Gan To Kagaku Ryoho 2001 28 7 989 992 Japanese 11478149
   PubMedGoogle Scholar
• Petrache I Birukova A Ramirez SI Garcia JG Verin AD The role of the microtubules in tumor necrosis factor-ainduced endothelial cell permeability Am J Respir Cell Mol Biol 2003 28 5 574 581 12707013
   PubMed Web of Science ®Google Scholar
• Birukova AA Smurova K Birukov KG Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: role of Rho-dependent mechanisms J Cell Physiol 2004 201 1 55 70 15281089
   PubMed Web of Science ®Google Scholar
• Kielbassa K Schmitz C Gerke V Disruption of endothelial microfilaments selectively reduces the transendothelial migration of monocytes Exp Cell Res 1998 243 1 129 141 9716457
   PubMed Web of Science ®Google Scholar
• Roberts RL Nath J Friedman MM Gallin JI Effects of taxol on human neutrophils J Immunol 1982 129 5 2134 2141 6126502
   PubMed Web of Science ®Google Scholar
• Lee M Jeon YJ Paclitaxel-Induced Immune Suppression is sociated with NF-κB Activation Via Conventional PKC Isotypes in Lipopolysaccharide-Stimulated 70Z/3 Pre-B Lymphocyte Tumor Cells Mol Pharmacol 2001 59 2 248 253 11160860
   PubMed Web of Science ®Google Scholar
• Byrd CA Bornmann W Erdjument-Bromage H Heat shock protein 90 mediates macrophage activation by Paclitaxel and bacterial lipopolysaccharide Proc Natl Acad Sci U S A 1999 96 10 5645 5650 10318938
   PubMed Web of Science ®Google Scholar
• Lee M Yea SS Jeon YJ Paclitaxel causes mouse splenic lymphocytes to a state hyporesponsive to lipopolysaccharide stimulation Int J Immunopharmacol 2000 22 8 615 621 10988356
   PubMed Web of Science ®Google Scholar
• Shimazu R Akashi S Ogata H MD-2, a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4 J Exp Med 1999 189 11 1777 1782 10359581
   PubMed Web of Science ®Google Scholar
• Zimmer SM Liu J Clayton JL Paclitaxel binding to human and murine MD-2 J Biol Chem 2008 283 41 27916 27926 18650420
   PubMed Web of Science ®Google Scholar
• Resman N Gradisar H Vasl J Taxanes inhibit human TLR4 signaling by binding to MD-2 FEBS Lett 2008 582 28 3929 3934 18977229
   PubMed Web of Science ®Google Scholar
• Zhang D Li Y Liu Y Paclitaxel ameliorates lipopolysaccharide-induced kidney injury by binding myeloid differentiation protein-2 to block Toll-like receptor 4-mediated nuclear factor-κB activation and cytokine production J Pharmacol Exp Ther 2013 345 1 69 75 23318472
   PubMed Web of Science ®Google Scholar
• Sengottuvel V Leibinger M Pfreimer M Andreadaki A Fischer D Taxol Facilitates Axon Regeneration in the Mature CNS J Neurosci 2011 31 7 2688 2699 21325537
   PubMed Web of Science ®Google Scholar
• Werk M Langner S Reinkensmeier B Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial Circulation 2008 118 13 1358 1365 18779447
   PubMed Web of Science ®Google Scholar
• Siablis D Karnabatidis D Katsanos K Diamantopoulos A Christeas N Kaqadis GC Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: midterm angiographic and clinical results J Vasc Interv Radiol 2007 18 11 1351 1361 18003984
   PubMed Web of Science ®Google Scholar
• Schmidt A Piorkowski M Werner M First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome J Am Coll Cardiol 2011 58 11 1105 1109 21884945
   PubMed Web of Science ®Google Scholar
• Cafasso D Schneider P How paclitaxel can improve results in diabetics J Cardiovasc Surg (Torino) 2012 53 1 13 21
   Web of Science ®Google Scholar
• Indolfi C Coppola C Torella D Arcucci O Chiariello M Gene therapy for restenosis after balloon angioplasty and stenting Cardiol Rev 1999 7 6 324 331 11208244
   PubMedGoogle Scholar
• Tepe Gunnar Scheller Bruno Speck Ulrich Paclitaxel-coated angioplasty catheters for local drug delivery Diagn Interv Radiol 2007 13 2 61 63 17562508
   PubMed Web of Science ®Google Scholar
• Park SJ Shim WH Ho DS A paclitaxel-eluting stent for the prevention of coronary restenosis N Engl J Med 2003 348 16 1537 1545 12700373
   PubMed Web of Science ®Google Scholar
• Gershlick A De Scheerder I Chevalier B Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial Circulation 2004 109 4 487 493 14744971
   PubMed Web of Science ®Google Scholar
• Milewski K Afari ME Tellez A Evaluation of efficacy and dose response of different paclitaxel-coated balloon formulations in a novel swine model of iliofemoral in-stent restenosis JACC Cardiovasc Interv 2012 5 10 1081 1088 23078739
   PubMed Web of Science ®Google Scholar
• Byrne RA Neumann FJ Mehilli J Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial Lancet 2013 381 9865 461 467 23206837
   PubMed Web of Science ®Google Scholar
• Sonoda S Honda Y Kataoka T Bonneau HN Taxol-based eluting stents from theory to human validation: clinical and intravascular ultrasound observations J Invasive Cardiol 2003 15 3 109 114 12612382
   PubMedGoogle Scholar
• Pires NMM Eefting D de Vries MR Quax PHA Jukema JW Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries Heart 2007 93 8 922 927 17449502
   PubMed Web of Science ®Google Scholar